BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, June 17, 2025
Breaking News: Trump administration impacts continue to roil the life sciences sector
See today's BioWorld Science
Home
» Roquefort Therapeutics reports in vitro results from MDK mRNA program in breast and liver cancer
To read the full story,
subscribe
or
sign in
.
Cancer
Roquefort Therapeutics reports in vitro results from MDK mRNA program in breast and liver cancer
June 14, 2023
Roquefort Therapeutics plc has successfully completed in vitro studies for its anticancer mRNA therapeutic in breast and liver cancer.
BioWorld Science
Cancer
